Chargement en cours...
Clinical trial designs incorporating predictive biomarkers()
Development of oncologic therapies has traditionally been performed in a sequence of clinical trials intended to assess safety (phase I), preliminary efficacy (phase II), and improvement over the standard of care (phase III) in homogeneous (in terms of tumor type and disease stage) patient populatio...
Enregistré dans:
| Publié dans: | Cancer Treat Rev |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4737867/ https://ncbi.nlm.nih.gov/pubmed/26827695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2015.12.008 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|